|
Ablynx
@
AblynxABLX
Ghent/Zwijnaarde, Belgium
|
|
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.
|
|
|
232
Tweets
|
145
Following
|
1,520
Followers
|
| Tweets |
| Ablynx retweeted | ||
|
BioVox
@BioVoxBelgium
|
Jul 26 |
|
FDA designates @AblynxABLX top nanobody caplacizumab fast track designation: 6-10 months faster approval $ABLX bit.ly/2uYfL1p pic.twitter.com/8nQrrbGNeF
|
||
|
||
| Ablynx retweeted | ||
|
European Biotech
@EuroBiotechNews
|
Jul 20 |
|
2.4bn "bioeuro": Belgian Nanobody delights now also tasteful in France @AblynxABLX @sanofi european-biotechnology.com/up-to-date/lat… pic.twitter.com/neEZrKEzgv
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Jul 19 |
|
#AblynxABLX and Sanofi to develop up to 8 Nanobody®-based therapeutics focused on immuno-inflammatory diseases ow.ly/1XJ430dLTBz
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Jun 26 |
|
#AblynxABLX achieves second milestone in immuno-oncology collaboration with Merck & Co., Inc. ow.ly/gmAQ30cV2nD
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Jun 25 |
|
#AblynxABLX initiates a single and multiple dose Phase I study of caplacizumab in healthy Japanese subjects
ow.ly/GuTe30cSSch
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 29 |
|
#AblynxABLX launches UnderstandingTTP.com, a new website dedicated to Thrombotic Thrombocytopenic Purpura (TTP) pic.twitter.com/dImaLrUnNK
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 21 |
|
#AblynxABLX receives €15M milestone from Merck KGaA for novel Nanobody in osteoarthritis ow.ly/p78h30bVeUW
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 18 |
|
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 11 |
|
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 10 |
|
#AblynxABLX Q1 2017 "Positive start of the year; good progress in multiple programmes; strong cash position" ow.ly/MCi530bCEiD
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 10 |
|
#AblynxABLX Publication in Journal of Thrombosis and Haemostasis "Caplacizumab reduces major thromboembolic events" ow.ly/6rp930bATqu
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
May 2 |
|
#AblynxABLX successfully completes patient recruitment in its Phase III Hercules study of caplacizumab ow.ly/wABy30blDC1
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Apr 7 |
|
#AblynxABLX Annual Report 2016 is available online - view via ow.ly/aXBY30aFdvx pic.twitter.com/iMO2H4tfHH
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Apr 7 |
|
@AblynxABLX - Adrianus van Herk (aandeelhouder Ablynx): 'België en Nederland zijn wereldtop' trends.knack.be/economie/bedri… via @trends
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Mar 16 |
|
@AblynxABLX - Ablynx, Mifratel en In The Pocket zijn de Ambassadeurs van de Oost-Vlaamse Gazellen trends.knack.be/economie/bedri… via @trends
|
||
|
|
||
| Ablynx retweeted | ||
|
|
BioVox
@BioVoxBelgium
|
Mar 6 |
|
Compelling data for @AblynxABLX developed psoriasis nanobody in @merckgroup collaboration bit.ly/2lNtkbN pic.twitter.com/agz75PZjC6
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Mar 2 |
|
@AblynxABLX Nog een aantal plaatsen vrij voor de Shareholders Club van 8 maart om 17u30. Interesse ? Registreer via investors@ablynx.com
|
||
|
|
||
| Ablynx retweeted | ||
|
Rare Disease Day
@rarediseaseday
|
Feb 28 |
|
Good morning to those waking up in Europe, Africa and the Middle East! Share with us what you have planned for today! #RareDiseaseDay
|
||
|
|
||
| Ablynx retweeted | ||
|
BCF Career
@BCFCareer
|
Feb 24 |
|
@BCFCareer you will find out that @AblynxABLX is dedicated to creating new medicines which will make a real difference to society! #BCF2017 pic.twitter.com/uDLrFCXqLK
|
||
|
|
||
|
|
Ablynx
@AblynxABLX
|
Feb 22 |
|
#AblynxABLX FYR 2016: significant progress in R&D pipeline; strong cash position; major catalysts in 2017. ow.ly/TmT2309h6zQ
|
||
|
|
||